Brewin Dolphin Wealth Management LTD Jazz Pharmaceuticals PLC Transaction History
Brewin Dolphin Wealth Management LTD
- $917 Million
- Q2 2022
A detailed history of Brewin Dolphin Wealth Management LTD transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Brewin Dolphin Wealth Management LTD holds 250 shares of JAZZ stock, worth $35,057. This represents 0.0% of its overall portfolio holdings.
Number of Shares
250
Previous 250
-0.0%
Holding current value
$35,057
Previous $39,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding JAZZ
# of Institutions
544Shares Held
59MCall Options Held
125KPut Options Held
58.4K-
Black Rock Inc. New York, NY6.15MShares$862 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.04MShares$846 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.53MShares$355 Million0.72% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.21MShares$311 Million0.67% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.04MShares$285 Million0.06% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $8.79B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...